Kavirajan HC, Lueck K, Chuang K. Alternating current cranial electrotherapy stimulation (CES) for depression. Cochrane
Database Syst Rev. 2014 Jul 8;7:CD010521. doi: 10.1002/14651858.CD010521.pub2
Kavirajan, H. “Memantine: A comprehensive review of safety and efficacy.” Expert Opinion on Drug Safety, January 2009
Kavirajan H, Hays RD, Vassar S, Vickrey B. “Responsiveness and validity of the HUI (Health Utilities Index) in persons with
dementia.” Medical Care, June 2009
Kavirajan H, Schneider LS. “Efficacy and adverse effects of cholinesterase inhibitors and memantine in vascular dementia: a
meta-analysis of randomised controlled trials.” Lancet Neurology; Sept 2007: 6:782-92.
Kavirajan, H. “Benefits of cognitive-motor intervention in MCI and mild to moderate Alzheimer disease.” (Letter) Neurology.
2005 Jul 26; 65(2):338-9.
Ali, AA, Espinoza R, Kavirajan H, Read S. “The effect of risperidone on nursing burden associated with caring for patients with
dementia.” (Letter). J Am Geriatr Soc. 2005 Jul;53(7):1261-2.
Kavirajan, H. “Venlafaxine and SSRI Remission Data Revisited.” (Letter) Br J Psychiatry. 2004 May; 184:452-3.
Kavirajan, H. “The Amobarbital Interview Revisited: A Review of the Literature Since 1966,” The Harvard Review of
Psychiatry, Sept-Oct ’99.
Kavirajan H, Vahia I, Thompson W, Depp C, Allison M, Jeste D. “Attitude toward own own aging and mental health in post-
menopausal women.” Asian Journal of Psychiatry. March 2001; 4:1:26-30.
Vahia I, Chatillion E, Kavirajan H, Depp CA. "Psychological Protective Factors Across the Lifespan: Implications for Psychiatry."
Psychiatric Clinics of North America. March 2011: 34:1: 231-48.
Associate Editor for Cochrane Clinical Answers
Reviewer for American Journal of Psychiatry
American Journal of Geriatric Psychiatry
Clinical Drug Investigation
Health and Quality of Life Outcomes